Patent · US Active

Tau immunotherapy

US10501531B2 · kind B2 · utility

14Cited by
1References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2014
Grant dateDec 10, 2019
Priority date—
Expiry dateNov 22, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2821
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.